טוען...
Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
BACKGROUND: Migraine prevention with erenumab and migraine induction by calcitonin gene-related peptide (CGRP) both carry notable individual variance. We wanted to explore a possible association between individual efficacy of anti-CGRP treatment and susceptibility to migraine induction by CGRP. METH...
שמור ב:
| הוצא לאור ב: | J Headache Pain |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Milan
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755614/ https://ncbi.nlm.nih.gov/pubmed/30409109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0927-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|